Announcements
Sidley Represents BioRender in Investment Valuing Company at $900 Million
January 2, 2026
Sidley represented BioRender, a scientific communication platform with the mission of accelerating the world’s ability to learn, discover, and communicate science, in connection with a strategic investment from Dimension Capital that values the company at approximately $900 million. As part of the transaction, BioRender provided liquidity to its employees.
The Sidley team was led by Michael Podolny (Emerging Companies and Venture Capital), and included Chloe Kaufman and Celine Gruaz (Emerging Companies and Venture Capital); Nicholas Frey (Employee Benefits and Executive Compensation); and Jonathan Westreich (Tax).
Contacts
Capabilities
Suggested News & Insights
Sidley, Innovation Endeavors, and Premji Happy Hour Reception at JPMTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027Sidley Continues Strategic Growth of Global Life Sciences Practice With Addition of Corporate Lawyers Deepa Rich and Sam ZuckerNovember 18, 2026Sidley Represents Dechra in Acquisition of Gallant PetNovember 18, 2026Sidley Represents RemeGen in Expanded US$356 Million Licensing Agreement With Vor BioNovember 16, 2026Sidley Represents Clearlake Capital Group in Mirendil’s US$1 Billion FinancingNovember 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


